Propolis power: scientists track how beehive compound enters the bloodstream

NCT ID NCT07681310

Knowledge-focused Sponsor: Fytexia Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 02, 2026 · Last updated Jul 02, 2026

Summary

This study looks at how a specific type of propolis extract, called GreenArt, is absorbed and processed by the body. Ten healthy adults will take either a low dose, a high dose, or a placebo, and researchers will measure the levels of beneficial plant compounds in their blood and urine over 48 hours. The goal is to understand how well these compounds enter the bloodstream and how quickly the body eliminates them.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
GreenArt (baccharis-type propolis extract)
What this could lead to
If successful, this research could help determine the optimal dose and formulation of propolis supplements for better absorption.
What could go wrong
This is a small, early-stage study in healthy people, so results may not apply to broader populations or show any health benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 10 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jun 2026

An estimate. Start dates often move.

Expected to finish

Jul 2026

An estimate. End dates often move.

Lead sponsor

A company

The lead sponsor is a pharmaceutical, biotech, or medical-device company.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

25 to 69 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Provision of signed and dated informed consent form. 2. Stated willingness to comply with all study procedures and availability for the duration of the study. 3. Male and female with 40% min. and 60% max. of each sex. 4. Aged 25 to 69 years old 5. BMI range (18.5 - 29.99) 6. In good general health as evidenced by medical history 7. Ability to take oral supplementation and be willing to adhere to the regimen 8. Agreement to adhere to Lifestyle Considerations (controlled diet) throughout study duration Exclusion Criteria: 1. Current use of any medication or food supplement 2. Antibiotic use less than 12 weeks before the study 3. Pregnancy or lactation 4. Known allergic reactions to components of the supplement, i.e., bee products (specially propolis) and known allergy (general) 5. Metabolic disorders or any kind of disease 6. Current smoker

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Nutrition, healthy are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • UCAM Universidad Católica San Antonio de Murcia

    Guadalupe, Murcia, 30107, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.